Corporate Overview
Aurora Spine is an emerging growth company focused on bringing new solutions to the spinal implant market through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Aurora Spine continues to position itself at the forefront of spinal surgery procedures, focusing on minimally invasive spine surgery technologies. Aurora Spine is changing spine surgery by focusing on disruptive technologies following the Company’s commitment to Simplify the Complex.
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2024 Financial Results
Third Quarter 2024 Conference Call Details
Date and Time:
Monday, October 28, 2024, at 11:00 a.m. ET / 8:00 a.m. PT
2024 Annual Shareholder Meeting
Press Releases
March 11, 2025 - Aurora Spine to Attend the American Academy of Orthopaedic Surgeons Annual Meeting
January 22, 2025 - Aurora Spine Announces Leadership Promotions: Matt Paxton, Executive Vice President of Sales, and Katelyn Sims, Area Vice President of Commercialization and Key Accounts
October 25, 2024 - Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2024 Financial Results
October 24, 2024 - Aurora Spine Corporation Announces Third Quarter 2024 Financial Results
October 15, 2024 - Aurora Spine Corporation Announces Release of its Hydra Osteo Onyx Lumbar System
September 24, 2024 - Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
September 11, 2024 - Aurora Spine to Host ZOOM Call with Alpha Wolf Trading CEO Tim Weintraut
September 05, 2024 - Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets
August 21, 2024 - Aurora Spine Corporation Announces Second Quarter 2024 Financial Results
May 13, 2024 - Aurora Spine Corporation Announces First Quarter 2024 Financial Results
April 29, 2024 - Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2023 Financial Results
February 05, 2024 - Aurora Spine’s Second Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office
January 29, 2024 - The United States Patent Office Grants New Patent for Aurora Spine’s Translucent GhostTube™ Surgical Operating Tube
January 18, 2024 - AURORA SPINE ANNOUNCES ATTENDANCE AT NORTH AMERICAN NEUROMODULATION SOCIETY (NANS) ANNUAL MEETING
January 08, 2024 - Aurora Spine Announces Attendance at J.P. Morgan Healthcare Conference
December 04, 2023 - Aurora Spine Corporation Announces Newly Published Paper on First 6-month Clinical Evaluation of its ZIP™ Fusion Implant
November 17, 2023 - Aurora Spine Grants Stock Options
November 14, 2023 - Aurora Spine Corporation Announces Third Quarter Fiscal 2023 Financial Results
November 13, 2023 - Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2023 Financial Results
October 23, 2023 - AURORA SPINE ANNOUNCES CLOSING OF PRIVATE PLACEMENT FINANCING
September 13, 2023 - Aurora Spine Announces Full Release of its SiLO TFX™ MIS Sacroiliac Joint Fixation System
Investor Presentations
Please check this section often for investor related events, webcasts, and corporate presentations
Aurora Spine Corporation Fireside Chat @ Lytham Partners 2025 Investor Healthcare Summit
The webcast presentation for the Lytham Partners Spring 2022 Investor Conference is a Panel Discussion titled Simplifying the Complex – A Panel Discussion with Doctors that Use Aurora Products. Access the video here.
Aurora Spine Corp. Panel Presentation @ Lytham Partners Spring 2022 Investor Conference